An uncommon increased incidence of new-onset diabetes has been observed in patients with coronavirus disease 2019 (COVID-19) (1). The recent interesting article by Khunti et al. (1) has summarized the potential mechanisms for newly diagnosed diabetes associated with COVID-19; in addition, they gave recommendations for the management of patients with diabetes associated with COVID-19 and suggestions for future research (1). Even if the precise mechanisms of new-onset diabetes in people with COVID-19 are not fully understood at the moment, several processes, such as previously undiagnosed diabetes, stress hyperglycemia, steroid-induced hyperglycemia, and direct or indirect effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection, have been taken into account and reported in the article (1).
Patiëntvoorbeelden m.b.t. vergoeding
- ten laste van verzekeraar
- geen vergoeding door verzekeraar